» Articles » PMID: 32386230

Long-Term Intake of Dietary Carotenoids Is Positively Associated with Late-Life Subjective Cognitive Function in a Prospective Study in US Women

Overview
Journal J Nutr
Publisher Elsevier
Date 2020 May 10
PMID 32386230
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A protective association of dietary carotenoids with cognitive function has been suggested, but most studies have been relatively small with limited periods of follow-up.

Objectives: We examined prospectively long-term intakes of carotenoids in relation to subjective cognitive function (SCF), a self-reported, validated indicator of cognitive dysfunction.

Methods: Among 49,493 female registered nurses with a mean age of 48 y in 1984, we used multinomial logistic regression to estimate the ORs and 95% CIs relating intakes of carotenoids to self-reported SCF in 2012 and 2014. Mean intakes of carotenoids were calculated from 7 repeated FFQs collected in 1984, 1986, and every 4 y afterwards until 2006. Self-reported SCF was assessed by a 7-item questionnaire on changes in memory and cognition; validity was supported by strong associations with Apolipoprotein E (APOE) ε4 genotype and concurrent cognitive function and cognitive decline measured by telephone-based neuropsychological tests. The mean values of scores assessed in 2012 and 2014 were categorized as "good" (0 points, 40.8%), "moderate" (0.5-2.5 points, 46.9%), and "poor" (3-7 points, 12.3%).

Results: Higher intake of total carotenoids was associated with substantially lower odds of moderate or poor cognitive function after controlling for other dietary and nondietary risk factors and total energy intake. Comparing the top with the bottom quintile of total carotenoids, the multivariable ORs were 0.86 (95% CI: 0.80, 0.93; P-trend < 0.001) for moderate SCF and 0.67 (95% CI: 0.60, 0.75; P-trend < 0.001) for poor SCF. This lower OR was also seen for carotenoids consumed 28 y before SCF assessment. Similar associations were found for total β-carotene, dietary β-carotene, α-carotene, lycopene, lutein + zeaxanthin, and β-cryptoxanthin. The significant associations for β-cryptoxanthin, lycopene, and lutein + zeaxanthin persisted after mutual adjustment for each other.

Conclusions: Our findings support a long-term beneficial role of carotenoid consumption on cognitive function in women.

Citing Articles

Dietary Strategies to Mitigate Alzheimer's Disease: Insights into Antioxidant Vitamin Intake and Supplementation with Microbiota-Gut-Brain Axis Cross-Talk.

Wan Ngah W, Ahmad H, Ankasha S, Makpol S, Tooyama I Antioxidants (Basel). 2025; 13(12.

PMID: 39765832 PMC: 11673287. DOI: 10.3390/antiox13121504.


β-Carotene Impacts the Liver MicroRNA Profile in a Sex-Specific Manner in Mouse Offspring of Western Diet-Fed Mothers: Results from Microarray Analysis by Direct Hybridization.

Abrego-Guandique D, Galmes S, Garcia-Rodriguez A, Cannataro R, Caroleo M, Ribot J Int J Mol Sci. 2024; 25(23).

PMID: 39684610 PMC: 11641259. DOI: 10.3390/ijms252312899.


Association Between Dietary Diversity and Subjective Cognitive Decline in the Middle-Aged and Elderly Chinese Population: A Cross-Sectional Study.

Gao M, Wang J, Qiu Y, Chen Y, Cao Q, Pan Y Nutrients. 2024; 16(21).

PMID: 39519436 PMC: 11548035. DOI: 10.3390/nu16213603.


Lutein and zeaxanthin reduce neuronal cell damage caused by lipid peroxidation.

Morita S, Sueyasu T, Tokuda H, Kaneda Y, Izumo T, Nakao Y Biochem Biophys Rep. 2024; 40:101835.

PMID: 39398539 PMC: 11470167. DOI: 10.1016/j.bbrep.2024.101835.


Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Flieger J, Forma A, Flieger W, Flieger M, Gawlik P, Dzierzynski E Int J Mol Sci. 2024; 25(16).

PMID: 39201668 PMC: 11354426. DOI: 10.3390/ijms25168982.


References
1.
Scheef L, Spottke A, Daerr M, Joe A, Striepens N, Kolsch H . Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology. 2012; 79(13):1332-9. DOI: 10.1212/WNL.0b013e31826c1a8d. View

2.
Launer L . The epidemiologic study of dementia: a life-long quest?. Neurobiol Aging. 2005; 26(3):335-40. DOI: 10.1016/j.neurobiolaging.2004.03.016. View

3.
Radmanesh F, Devan W, Anderson C, Rosand J, Falcone G . Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data. Eur J Hum Genet. 2014; 22(10):1239-42. PMC: 4169533. DOI: 10.1038/ejhg.2013.308. View

4.
Ramos Cordero P, Yubero R . [Non-pharmacological treatment of cognitive impairment]. Rev Esp Geriatr Gerontol. 2016; 51 Suppl 1:12-21. DOI: 10.1016/S0211-139X(16)30138-X. View

5.
Dias I, Polidori M, Li L, Weber D, Stahl W, Nelles G . Plasma levels of HDL and carotenoids are lower in dementia patients with vascular comorbidities. J Alzheimers Dis. 2014; 40(2):399-408. PMC: 4230763. DOI: 10.3233/JAD-131964. View